Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 150 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 120 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 100 mg, mg/ml,

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 80 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 60 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 40 mg

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

techdow pharma netherlands b.v, netherlands - enoxaparin sodium - solution for injection - 20 mg

European Union - English - EMA (European Medicines Agency)

techdow pharma netherlands b.v.  - enoxaparin sodium - venous thromboembolism - antithrombotic agents - inhixa is indicated for adults for:prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery.prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 ml).treatment of deep vein thrombosis (dvt), complicated or uncomplicated by pulmonary embolism.treatment of unstable angina and non q wave myocardial infarction, in combination with acetylsalicylic acid (asa).treatment of acute st segment elevation myocardial infarction (stemi) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 ml, 80 mg/0.8 ml, and 100 mg/1 ml).blood clot prevention in the extracorporeal circulation during haemodialysis.

European Union - English - EMA (European Medicines Agency)

pharmathen s.a. - enoxaparin sodium - venous thromboembolism - antithrombotic agents - thorinane is indicated for adults for: - prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery. - prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 ml). - treatment of deep vein thrombosis (dvt), complicated or uncomplicated by pulmonary embolism. - treatment of unstable angina and non q wave myocardial infarction, in combination with acetylsalicylic acid (asa). - treatment of acute st segment elevation myocardial infarction (stemi) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 ml, 80 mg/0.8 ml, and 100 mg/1 ml). - blood clot prevention in the extracorporeal circulation during haemodialysis. prevention and treatment of various disorders related to blood clots in adults.,

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

techdow pharma england ltd - enoxaparin sodium - solution for injection - 100mg/1ml